Clinicians prescribed antibiotics without an infection-related diagnosis nearly half of the time and one in five prescriptions were provided without an in-person visit, according to research being presented...

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or locally...

The U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium...

The U.S. Food and Drug Administration this week approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell...

Grifols, a leading global producer of plasma-derived medicines, announced that the U.S. Food and Drug Administration (FDA) has approved a new formulation of its GamaSTAN® immune globulin (human) for...

An international team of researchers from CDDEP, Australian National University and Cardiff University and the Monarch Institute has published a new study showing that the proliferation of disease-causing...

Scientists have traditionally believed that combining more than two drugs to fight harmful bacteria would yield diminishing returns. The prevailing theory is that that the incremental benefits of combining...

Watertown, MA biopharmaceutical company, Tetraphase Pharmaceuticals, Inc. announced Monday that the US Food and Drug Administration (FDA) has granted approval of XERAVA™ (eravacycline) for the treatment...

Antibiotics are among the most commonly prescribed medications in children, but they can lead to adverse drug events and should be used only when needed. From 2011-2015, antibiotic use in children led...

Alachua, Florida biologics contract development and manufacturing organization (CDMO), Ology Bioservices, Inc., announced this week that it was awarded an Other Transaction Agreement (OTA) to support the...